scholarly article | Q13442814 |
P50 | author | Toshihiro Sashihara | Q89551169 |
P2093 | author name string | Satoru Suzuki | |
Satoshi Hachimura | |||
Takayuki Toshimitsu | |||
Nobuhiko Shioya | |||
Ayako Gotou | |||
Yukio Asami | |||
P2860 | cites work | Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis | Q21146684 |
Obesity, Inflammation, and Insulin Resistance | Q22250939 | ||
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
Low-grade inflammation, diet composition and health: current research evidence and its translation | Q26801350 | ||
Seasonal variation of haemoglobin A1c in a Portuguese adult population. | Q50539823 | ||
Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome. | Q51355563 | ||
Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. | Q51572651 | ||
Daily Yogurt Consumption Improves Glucose Metabolism and Insulin Sensitivity in Young Nondiabetic Japanese Subjects with Type-2 Diabetes Risk Alleles | Q60929186 | ||
Physical Activity Earlier in Life Is Inversely Associated With Insulin Resistance Among Adults in Japan | Q61799337 | ||
The Effect of Probiotic Yogurt on Glycemic Control in Type 2 Diabetes or Obesity: A Meta-Analysis of Nine Randomized Controlled Trials | Q64072092 | ||
Effects of long-term intake of a yogurt fermented with Lactobacillus delbrueckii subsp. bulgaricus 2038 and Streptococcus thermophilus 1131 on mice | Q64124741 | ||
Novel dipeptidyl peptidase-4-inhibiting peptide derived from β-lactoglobulin | Q84750557 | ||
Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study | Q90017557 | ||
Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics | Q90457180 | ||
Daily intake of heat-killed Lactobacillus plantarum L-137 improves inflammation and lipid metabolism in overweight healthy adults: a randomized-controlled trial | Q90761940 | ||
Leaky gut: mechanisms, measurement and clinical implications in humans | Q91928630 | ||
The Impact of Dairy Products in the Development of Type 2 Diabetes: Where Does the Evidence Stand in 2019? | Q92264899 | ||
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials | Q29620359 | ||
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes | Q30548796 | ||
Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials. | Q33853394 | ||
Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies | Q34515543 | ||
Normalization of obesity-associated insulin resistance through immunotherapy | Q34994222 | ||
Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome. | Q36049114 | ||
Adipose tissue, adipokines, and inflammation | Q36114223 | ||
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis | Q36158245 | ||
Seasonal variation in hemoglobin A1c: is it the same in both hemispheres? | Q37404569 | ||
Inflammatory components of adipose tissue as target for treatment of metabolic syndrome | Q37444496 | ||
Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts | Q37888695 | ||
Roles of the gut in the metabolic syndrome: an overview | Q38780926 | ||
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. | Q38822669 | ||
Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction | Q39133345 | ||
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB. | Q39307209 | ||
Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes. | Q39374045 | ||
Effects of Lactobacillus plantarum Strain OLL2712 Culture Conditions on the Anti-inflammatory Activities for Murine Immune Cells and Obese and Type 2 Diabetic Mice | Q41728255 | ||
Identification of a Lactobacillus plantarum strain that ameliorates chronic inflammation and metabolic disorders in obese and type 2 diabetic mice | Q42816654 | ||
Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects | Q42918043 | ||
Seasonal variation in metabolic syndrome prevalence | Q43124444 | ||
Seasonal variation of glycemic control in type 2 diabetic patients | Q43687941 | ||
Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57BL/6 mice fed a high-fat diet | Q43902429 | ||
Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial | Q44083134 | ||
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). | Q44333619 | ||
Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management | Q46585602 | ||
Yogurt Is a Low-Glycemic Index Food | Q47345964 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | placebo | Q269829 |
Lactobacillus plantarum | Q1756682 | ||
placebo-controlled trial | Q108853737 | ||
P577 | publication date | 2020-01-31 | |
P1433 | published in | Nutrients | Q7070485 |
P1476 | title | Effects of 12-Week Ingestion of Yogurt Containing Lactobacillus plantarum OLL2712 on Glucose Metabolism and Chronic Inflammation in Prediabetic Adults: A Randomized Placebo-Controlled Trial | |
P478 | volume | 12 |
Search more.